查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1924719

O型臂市場依採購模式、服務類型、應用、最終用戶和通路分類－2026-2032年全球預測

O-arm Market by Purchase Model, Service Type, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，O 型臂市場價值將達到 3.2009 億美元，到 2026 年將成長到 3.647 億美元，到 2032 年將達到 8.245 億美元，年複合成長率為 14.47%。

關鍵市場統計數據
基準年 2025 3.2009億美元
預計年份：2026年 3.647億美元
預測年份 2032 8.245億美元
複合年成長率 (%) 14.47%

O型臂影像系統的策略應用：外科專科臨床價值提案、技術定位、報銷考量與應用促進因素框架

O型臂術中影像系統已成為外科團隊的核心考量因素，旨在將即時影像與導航和手術精準性相結合。現代醫院和門診手術中心在評估這些系統時，不僅關注影像質量，還關注其與導航平台、機器人助手和電子病歷工作流程的整合度。如何在降低再次手術率和縮短手術時間等臨床結果與手術室周轉率、人員能力和長期維護性等運作因素之間取得平衡，變得日益重要。

術中影像技術正經歷變革性轉變，人工智慧導航、機器人整合、先進顯像模式以及跨部門診療路徑重塑將帶來變革。

術中影像領域正經歷變革時期，其驅動力源自於影像硬體的改進、先進視覺化軟體的進步以及機器學習引導工具的融合。儘管影像擷取的精確度和速度有所提升，但更大的變革在於系統正朝著在手術過程中提供情境化臨床資訊的方向發展，使團隊能夠根據結構化的影像輸出進行即時調整。持續的軟體演進、模組化硬體設計以及增強的連接性，正為與導航平台和手術全期數據系統的整合開闢新的途徑。

評估美國2025年關稅對O型臂採購、全球供應鏈、零件成本、醫院資本規劃和合約策略的累積影響

近期影響關稅的政策舉措，為手術室設備採購計畫、供應鏈設計和定價策略引入了新的變數。關稅調整不僅影響整套系統的到岸成本，還會影響關鍵子組件和耗材（這些組件和耗材可能從國際採購）的經濟效益。採購團隊正在透過重新評估供應商多元化、協商延長服務協議以保障設備運作，以及探索能夠減輕近期資本負擔的資金籌措方案來應對這些變化。

細分市場分析：了解應用領域、最終用戶類型、購買模式、服務交付形式和通路對採用趨勢和生命週期經濟學的影響

透過對 O-Arm 生態系統的應用、最終用戶、採購模式、服務類型和分銷管道進行分析，揭示了不同臨床環境下的採用模式和支援需求存在差異。按應用領域分類，O-Arm 的應用主要集中在神經外科、整形外科、脊椎外科和創傷外科，其中神經外科又細分為功能性手術、腫瘤切除和血管介入。整形外科的應用主要集中在骨折固定和關節關節重建方面，而脊椎外科則分為微創手術和開放式脊椎手術。微創手術又進一步分為內視鏡手術和經皮手術。創傷應用主要集中在下肢和上肢創傷，每個創傷都有其獨特的成像和工作流程要求。

區域趨勢與應用模式：美洲、歐洲、中東和非洲以及亞太地區的基礎設施發展、報銷體係以及決定臨床應用軌蹟的因素

區域趨勢對採購方式、臨床訓練系統和報銷架構有顯著影響，進而影響術中影像系統的應用。在美洲，醫療系統和私人醫院優先考慮整合解決方案，以支援高手術量並符合綜合支付舉措。同時，在手術配置和報銷機制能夠實現當日手術的地區，門診應用率正在不斷提高。基礎設施建設的進展以及學術機構在某些大都會圈的集中，加速了先進成像技術的早期臨床檢驗和應用。

專注於產品差異化、策略聯盟、服務生態系統和市場進入策略的競爭考察，旨在推動永續的商業性優勢。

術中成像領域的主要企業正在尋求獨特的策略，以實現產品差異化並建立長期的客戶關係。一些企業優先考慮硬體創新，致力於提高影像清晰度、縮短擷取時間和簡化無菌區管理。另一些企業則專注於軟體生態系統，以增強導航功能、3D視覺化效果以及與電子病歷的互通性。還有一些企業則優先考慮服務融資結構，以降低中型醫院和門診手術中心採用該技術的門檻。

為產業領導者提供切實可行的策略建議，以加速臨床應用、降低整體擁有成本、增強售後市場收入並降低供應風險。

業界領導者應優先考慮一系列切實可行的舉措，以加速臨床應用，同時保障營運利潤和病患療效。首先，使產品藍圖與互通性標準保持一致，並與導航系統、手術機器人和手術全期IT平台建立清晰的整合路徑，以減少應用阻力，提升臨床團隊對產品價值的認知。其次，拓展靈活的商業模式，包括經營性租賃、分期付款購買選項以及與運作和療效指標掛鉤的綜合服務協議，以應對資金限制和採購偏好。

一套透明的調查方法，清楚地概述了用於得出戰略洞見的初級和二級研究、專家檢驗、分析框架和品管。

本報告的分析方法採用結構化的多源資料收集方法，結合了原始定性資料和嚴謹的二手檢驗。原始研究包括對臨床醫生、生物醫學工程師、採購主管和服務經理進行半結構式訪談，以了解設備整合、臨床工作流程和支援期望等方面的實際考量。訪談通訊協定強調開放式問題，旨在挖掘定量資料無法捕捉的臨床價值、員工培訓和決策因素的細緻觀點。

一份權威的執行摘要，概述了技術整合和服務交付方面的策略挑戰、實施障礙、機會領域和切實可行的後續步驟。

整合臨床、商業性和營運觀點，凸顯了術中成像解決方案相關相關人員的明確策略要務。首先，臨床認可取決於與現有手術流程的實際整合以及手術可靠性的可衡量提升。其次，商業性成功越來越依賴靈活的採購和服務模式，以減輕資金壓力並確保可預測的運作。第三，隨著全球政策和零件供應的不穩定性造成上游風險，供應鏈韌性和合約創新正從後勤部門考量上升到董事會層面的優先事項。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：O型臂市場採購模式

  • 租
    • 融資租賃
    • 經營租賃
  • 購買

第9章 依服務類型分類的O型臂市場

  • 內部服務
  • 外包服務

第10章 O型臂市場：依應用領域分類

  • 神經外科
    • 功能性
    • 腫瘤切除
    • 血管外科
  • 整形外科手術
    • 骨折固定
    • 關節重建
  • 脊椎手術
    • 微創脊椎手術
      • 內視鏡手術
      • 經皮
    • 開放式脊椎手術
  • 創傷外科

第11章 依最終用戶分類的O型臂市場

  • 門診手術中心
  • 診所
    • 綜合診所
    • 專科診所
  • 醫院

第12章 依分銷通路分類的O型臂市場

  • 離線
  • 線上

第13章 按地區分類的O型臂市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 依組別分類的O型臂市場

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國O型臂市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國O型臂市場

第17章：中國的O型臂市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Amico Corporation
  • Baxter International Inc.
  • BeaconMedaes LLC
  • Brandon Medical Co. Ltd.
  • CV Medical LLC
  • Dragerwerk AG & Co. KGaA
  • Fuji Booms Co., Ltd.
  • Getinge AB
  • Hipac Healthcare Pty Ltd.
  • KARL STORZ SE & Co. KG
  • Mediland Enterprise Corporation
  • Olympus Corporation
  • Ondal Medical Systems GmbH
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Sigma Medical Systems, Inc.
  • Skytron LLC
  • Starkstrom Limited
  • STERIS plc
  • Stryker Corporation
  • TRUMPF Medizin Systeme GmbH
Product Code: MRR-7A380DA7C44D

The O-arm Market was valued at USD 320.09 million in 2025 and is projected to grow to USD 364.70 million in 2026, with a CAGR of 14.47%, reaching USD 824.50 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 320.09 million
Estimated Year [2026] USD 364.70 million
Forecast Year [2032] USD 824.50 million
CAGR (%) 14.47%

O-arm Imaging Systems Strategic Introduction Framing Clinical Value Propositions, Technological Positioning, Reimbursement Considerations, and Adoption Drivers across Surgical Specialties

O-arm intraoperative imaging systems have become a central consideration for surgical teams aiming to combine real-time imaging with navigation and procedural precision. Modern hospitals and ambulatory centers evaluate these systems not only for image quality but for how they integrate with navigation platforms, robotic assistants, and electronic health record workflows. The decision calculus increasingly balances clinical outcomes such as reduced revision rates and procedure time against operational factors including room turnover, staffing competency, and long-term serviceability.

Clinicians view the O-arm as an enabler of targeted interventions across neurosurgery, spine, orthopedic, and trauma specialties, while procurement leaders assess capital deployment alongside aftermarket commitments. As device makers expand software capabilities, interoperability and data governance have emerged as pivotal criteria for adoption. Consequently, understanding the device's role within the broader digital operating room ecosystem is essential for stakeholders prioritizing patient safety, reproducibility of surgical workflows, and measurable improvements in procedural efficiency.

Transformative Shifts Reshaping Intraoperative Imaging Through AI-Enabled Navigation, Robotics Integration, Enhanced Imaging Modalities, and Cross-Sector Care Pathway Redesign

The intraoperative imaging landscape is undergoing a transformative phase driven by the convergence of imaging hardware improvements, advanced visualization software, and machine learning-enabled guidance tools. Image acquisition fidelity and speed have improved, but the greater shift is toward systems that deliver contextual clinical intelligence during procedures, enabling teams to make real-time adjustments based on structured imaging outputs. Continuous software evolution, modular hardware design, and enhanced connectivity are creating new pathways for integration with navigation platforms and perioperative data systems.

Alongside technical progress, clinical practice is changing: minimally invasive techniques and hybrid surgical suites are pushing demand for compact, flexible imaging solutions that minimize disruption to care pathways. Service delivery models are evolving as well, with providers emphasizing uptime guarantees, predictable maintenance costs, and outcome-linked service contracts. These changes are prompting device manufacturers and channel partners to re-evaluate product roadmaps, aftermarket plans, and clinical support structures to remain relevant in a rapidly modernizing surgical environment.

Assessing the Cumulative Impact of United States Tariffs 2025 on O-arm Procurement, Global Supply Chains, Component Costs, Hospital Capital Planning, and Contracting Strategies

Recent policy actions affecting tariffs have introduced new variables into procurement planning, supply chain design, and pricing strategies for capital equipment used in the operating room. Tariff adjustments influence not only the landed cost of finished systems but also the economics of key subcomponents and consumables that may be sourced internationally. Procurement teams are responding by reassessing supplier diversification, negotiating extended-service commitments to protect uptime, and exploring financing structures that mitigate near-term capital strain.

The cascading operational implications extend to contract negotiations with distributors and original equipment manufacturers, where clauses addressing long lead times, currency exposure, and component scarcity are becoming more prevalent. Health systems and ambulatory centers are adjusting capital budgeting cycles and instituting stronger cross-functional governance between clinical, finance, and supply chain teams to preserve access to critical technologies while maintaining cost discipline. In short, tariff-related pressures are reshaping sourcing strategies and contract design without diminishing clinical demand for robust intraoperative imaging capabilities.

Segmentation Insights Revealing How Application Areas, End User Types, Purchase Models, Service Offerings, and Distribution Channels Influence Adoption and Lifecycle Economics

Disaggregating the O-arm ecosystem by application, end user, purchase model, service type, and distribution channel reveals differentiated adoption patterns and support requirements across clinical settings. When analyzed by application, the system is deployed across neurosurgery, orthopedic surgery, spine surgery, and trauma surgery, with neurosurgery further segmented into functional procedures, tumor resection, and vascular interventions. Orthopedic deployment centers on fracture fixation and joint replacement use cases, while spine surgery adoption is divided between minimally invasive spine surgery and open spine surgery, with minimally invasive approaches further classified into endoscopic and percutaneous techniques. Trauma applications concentrate on lower extremity trauma and upper extremity trauma, each carrying unique imaging and workflow demands.

Considering end users, adoption varies among ambulatory surgical centers, clinics, and hospitals. Ambulatory surgical centers differentiate between hospital-owned and independent operators; clinics split into multi-specialty and specialty-focused establishments; and hospitals fall into academic and community categories, each with distinct purchasing authority and clinical priorities. Purchase models influence acquisition strategies, with choices between leasing and purchase; leasing can be structured as finance lease or operating lease, whereas purchase options include direct purchase and installment payment. Service type drives total cost considerations and clinical uptime priorities, with options for in-house service or outsourced service, the latter provided either as OEM-supported or via third-party service partners. Distribution channels encompass direct sales, online channels, and third-party distributors, and online channels include marketplaces and OEM portals while third-party distributors may be local or national in scope. These layered segmentations collectively determine procurement timelines, training programs, capital allocation, and aftermarket commitments, shaping how stakeholders evaluate the technology across use cases and organizational structures.

Regional Dynamics and Adoption Patterns Across Americas, Europe Middle East & Africa, and Asia-Pacific Determining Infrastructure Readiness, Reimbursement, and Clinical Uptake Trajectories

Regional dynamics exert a significant influence over procurement approaches, clinical training pipelines, and reimbursement frameworks that affect the uptake of intraoperative imaging systems. In the Americas, health systems and private hospitals tend to prioritize integrated solutions that support busy procedural volumes and align with bundled payment initiatives, while ambulatory adoption is rising where procedure mix and reimbursement permit same-day workflows. Infrastructure readiness and concentration of academic centers in certain metropolitan areas accelerate early clinical validation and diffusion of advanced imaging capabilities.

In Europe, Middle East & Africa, variability in regulatory pathways, public procurement practices, and reimbursement structures creates a mosaic of adoption rates. Northern and Western European centers often drive innovation adoption through tight clinical networks and centralized purchasing consortia, whereas emerging markets in the region prioritize cost-effective configurations and service models that limit downtime. In Asia-Pacific, rapid investments in specialty hospitals and an emphasis on minimally invasive techniques are fostering demand, tempered by the need for local training programs and supply chain localization. Across regions, differences in capital allocation cycles, clinical guidelines, and workforce training determine the sequence and scale of deployments, necessitating tailored go-to-market and support strategies for manufacturers and channel partners.

Competitive Company Insights Emphasizing Product Differentiation, Strategic Partnerships, Service Ecosystems, and Go-to-Market Tactics That Drive Sustainable Commercial Advantage

Leading companies in the intraoperative imaging space pursue distinct strategies to differentiate product offerings and secure long-term customer engagements. Some organizations focus on hardware innovations that improve image clarity, reduce acquisition time, and simplify sterile field management, while others emphasize software ecosystems that enhance navigation, 3D visualization, and interoperability with electronic health records. A third cohort prioritizes service and financing constructs that lower barriers to adoption for mid-sized hospitals and ambulatory surgical centers.

Strategic partnerships and channel diversification are common responses to distribution and service challenges. Manufacturers are expanding OEM relationships, forming alliances with navigation and robotics firms, and developing third-party servicing arrangements to broaden coverage. Aftermarket revenue is increasingly significant, incentivizing companies to offer modular upgrades, subscription-based software features, and outcome-oriented service agreements. Competitive positioning also reflects investments in clinical evidence generation, with companies sponsoring peer-reviewed studies and building evidence libraries that demonstrate procedural benefits and workflow efficiencies.

Actionable Strategic Recommendations for Industry Leaders to Accelerate Clinical Adoption, Reduce Total Cost of Ownership, Strengthen Aftermarket Revenue, and Mitigate Supply Risk

Industry leaders should prioritize a set of pragmatic initiatives that accelerate clinical adoption while protecting operational margins and patient outcomes. First, align product roadmaps with interoperability standards and establish clear integration pathways with navigation systems, surgical robotics, and perioperative IT platforms, thereby reducing implementation friction and increasing perceived value among clinical teams. Second, expand flexible commercial models that include operating leases, installment purchasing options, and bundled service agreements tied to uptime and outcome metrics to address capital constraints and procurement preferences.

Third, invest in regionalized training programs and virtual simulation to shorten the clinician learning curve and facilitate confidence in minimally invasive and hybrid procedures. Fourth, fortify supply chains by diversifying component sourcing, increasing transparency in lead times, and negotiating protective contract terms that share tariff and currency risk with key partners. Finally, develop scalable aftermarket offerings-remote monitoring, predictive maintenance, and subscription software services-that create recurring revenue streams and strengthen long-term customer relationships. Implementing these priorities in concert will help companies convert clinical interest into durable adoption while mitigating commercial and operational risk.

Transparent Research Methodology Outlining Primary and Secondary Data Collection, Expert Validation, Analytical Frameworks, and Quality Controls Used to Derive Strategic Insights

The analysis underpinning this report used a structured, multi-source approach combining primary qualitative input and rigorous secondary validation. Primary research included semi-structured interviews with clinicians, biomedical engineers, procurement leaders, and service managers to capture real-world considerations around device integration, clinical workflows, and support expectations. Interview protocols emphasized open-ended questions to elicit nuanced perspectives on clinical value, staff training, and decision drivers that quantitative sources may not capture.

Secondary research cross-referenced regulatory filings, peer-reviewed clinical literature, device manuals, and public procurement documents to corroborate themes emerging from interviews. Analytical protocols included triangulation of qualitative inputs against documented device capabilities and service offerings, and scenario analysis to examine how changes in procurement policies and supply dynamics could influence organizational behavior. Quality controls included multiple rounds of peer validation, traceable sourcing for key assertions, and anonymized expert review to ensure conclusions are grounded in verifiable inputs and robust reasoning.

Conclusive Executive Synthesis Summarizing Strategic Imperatives, Adoption Barriers, Opportunity Areas, and Practical Next Steps for Technology Integration and Service Delivery

The synthesis of clinical, commercial, and operational perspectives highlights a clear set of strategic imperatives for stakeholders engaged with intraoperative imaging solutions. First, clinical acceptance depends on demonstrable integration with existing surgical workflows and measurable improvements in procedural reliability. Second, commercial success is increasingly tied to flexible acquisition and service models that mitigate capital pressures and ensure predictable uptime. Third, supply chain resilience and contractual innovation have moved from back-office considerations to board-level priorities as global policy and component availability create upstream risks.

Taken together, these themes underscore the need for coordinated actions across product development, clinical affairs, and commercial teams. Manufacturers that combine interoperable technology, compelling clinical evidence, and adaptive commercial structures will be well positioned to support diverse provider needs. Providers that align procurement, clinical training, and maintenance planning will extract greater value from investments in imaging capabilities, ultimately improving procedural consistency and patient outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. O-arm Market, by Purchase Model

  • 8.1. Leasing
    • 8.1.1. Finance Lease
    • 8.1.2. Operating Lease
  • 8.2. Purchase

9. O-arm Market, by Service Type

  • 9.1. In-House Service
  • 9.2. Outsourced Service

10. O-arm Market, by Application

  • 10.1. Neurosurgery
    • 10.1.1. Functional
    • 10.1.2. Tumor Resection
    • 10.1.3. Vascular
  • 10.2. Orthopedic Surgery
    • 10.2.1. Fracture Fixation
    • 10.2.2. Joint Replacement
  • 10.3. Spine Surgery
    • 10.3.1. Minimally Invasive Spine Surgery
      • 10.3.1.1. Endoscopic
      • 10.3.1.2. Percutaneous
    • 10.3.2. Open Spine Surgery
  • 10.4. Trauma Surgery

11. O-arm Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Clinics
    • 11.2.1. Multi Specialty Clinics
    • 11.2.2. Specialty Clinics
  • 11.3. Hospitals

12. O-arm Market, by Distribution Channel

  • 12.1. Offline
  • 12.2. Online

13. O-arm Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. O-arm Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. O-arm Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States O-arm Market

17. China O-arm Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Amico Corporation
  • 18.6. Baxter International Inc.
  • 18.7. BeaconMedaes LLC
  • 18.8. Brandon Medical Co. Ltd.
  • 18.9. CV Medical LLC
  • 18.10. Dragerwerk AG & Co. KGaA
  • 18.11. Fuji Booms Co., Ltd.
  • 18.12. Getinge AB
  • 18.13. Hipac Healthcare Pty Ltd.
  • 18.14. KARL STORZ SE & Co. KG
  • 18.15. Mediland Enterprise Corporation
  • 18.16. Olympus Corporation
  • 18.17. Ondal Medical Systems GmbH
  • 18.18. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 18.19. Sigma Medical Systems, Inc.
  • 18.20. Skytron LLC
  • 18.21. Starkstrom Limited
  • 18.22. STERIS plc
  • 18.23. Stryker Corporation
  • 18.24. TRUMPF Medizin Systeme GmbH

LIST OF FIGURES

  • FIGURE 1. GLOBAL O-ARM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL O-ARM MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL O-ARM MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL O-ARM MARKET SIZE, BY PURCHASE MODEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL O-ARM MARKET SIZE, BY SERVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL O-ARM MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL O-ARM MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL O-ARM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL O-ARM MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL O-ARM MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL O-ARM MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES O-ARM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA O-ARM MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL O-ARM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL O-ARM MARKET SIZE, BY PURCHASE MODEL, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL O-ARM MARKET SIZE, BY LEASING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL O-ARM MARKET SIZE, BY LEASING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL O-ARM MARKET SIZE, BY LEASING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL O-ARM MARKET SIZE, BY LEASING, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL O-ARM MARKET SIZE, BY FINANCE LEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL O-ARM MARKET SIZE, BY FINANCE LEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL O-ARM MARKET SIZE, BY FINANCE LEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL O-ARM MARKET SIZE, BY OPERATING LEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL O-ARM MARKET SIZE, BY OPERATING LEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL O-ARM MARKET SIZE, BY OPERATING LEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL O-ARM MARKET SIZE, BY PURCHASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL O-ARM MARKET SIZE, BY PURCHASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL O-ARM MARKET SIZE, BY PURCHASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL O-ARM MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL O-ARM MARKET SIZE, BY IN-HOUSE SERVICE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL O-ARM MARKET SIZE, BY IN-HOUSE SERVICE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL O-ARM MARKET SIZE, BY IN-HOUSE SERVICE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL O-ARM MARKET SIZE, BY OUTSOURCED SERVICE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL O-ARM MARKET SIZE, BY OUTSOURCED SERVICE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL O-ARM MARKET SIZE, BY OUTSOURCED SERVICE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL O-ARM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL O-ARM MARKET SIZE, BY NEUROSURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL O-ARM MARKET SIZE, BY NEUROSURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL O-ARM MARKET SIZE, BY NEUROSURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL O-ARM MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL O-ARM MARKET SIZE, BY FUNCTIONAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL O-ARM MARKET SIZE, BY FUNCTIONAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL O-ARM MARKET SIZE, BY FUNCTIONAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL O-ARM MARKET SIZE, BY TUMOR RESECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL O-ARM MARKET SIZE, BY TUMOR RESECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL O-ARM MARKET SIZE, BY TUMOR RESECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL O-ARM MARKET SIZE, BY VASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL O-ARM MARKET SIZE, BY VASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL O-ARM MARKET SIZE, BY VASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL O-ARM MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL O-ARM MARKET SIZE, BY ORTHOPEDIC SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL O-ARM MARKET SIZE, BY ORTHOPEDIC SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL O-ARM MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL O-ARM MARKET SIZE, BY FRACTURE FIXATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL O-ARM MARKET SIZE, BY FRACTURE FIXATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL O-ARM MARKET SIZE, BY FRACTURE FIXATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL O-ARM MARKET SIZE, BY JOINT REPLACEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL O-ARM MARKET SIZE, BY JOINT REPLACEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL O-ARM MARKET SIZE, BY JOINT REPLACEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL O-ARM MARKET SIZE, BY SPINE SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL O-ARM MARKET SIZE, BY SPINE SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL O-ARM MARKET SIZE, BY SPINE SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL O-ARM MARKET SIZE, BY SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL O-ARM MARKET SIZE, BY MINIMALLY INVASIVE SPINE SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL O-ARM MARKET SIZE, BY MINIMALLY INVASIVE SPINE SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL O-ARM MARKET SIZE, BY MINIMALLY INVASIVE SPINE SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL O-ARM MARKET SIZE, BY MINIMALLY INVASIVE SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL O-ARM MARKET SIZE, BY ENDOSCOPIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL O-ARM MARKET SIZE, BY ENDOSCOPIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL O-ARM MARKET SIZE, BY ENDOSCOPIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL O-ARM MARKET SIZE, BY PERCUTANEOUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL O-ARM MARKET SIZE, BY PERCUTANEOUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL O-ARM MARKET SIZE, BY PERCUTANEOUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL O-ARM MARKET SIZE, BY OPEN SPINE SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL O-ARM MARKET SIZE, BY OPEN SPINE SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL O-ARM MARKET SIZE, BY OPEN SPINE SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL O-ARM MARKET SIZE, BY TRAUMA SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL O-ARM MARKET SIZE, BY TRAUMA SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL O-ARM MARKET SIZE, BY TRAUMA SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL O-ARM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL O-ARM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL O-ARM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL O-ARM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL O-ARM MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL O-ARM MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL O-ARM MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL O-ARM MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL O-ARM MARKET SIZE, BY MULTI SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL O-ARM MARKET SIZE, BY MULTI SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL O-ARM MARKET SIZE, BY MULTI SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL O-ARM MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL O-ARM MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL O-ARM MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL O-ARM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL O-ARM MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL O-ARM MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL O-ARM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL O-ARM MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL O-ARM MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL O-ARM MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL O-ARM MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL O-ARM MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL O-ARM MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL O-ARM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS O-ARM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS O-ARM MARKET SIZE, BY PURCHASE MODEL, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS O-ARM MARKET SIZE, BY LEASING, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS O-ARM MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS O-ARM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS O-ARM MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS O-ARM MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS O-ARM MARKET SIZE, BY SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS O-ARM MARKET SIZE, BY MINIMALLY INVASIVE SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS O-ARM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS O-ARM MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS O-ARM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA O-ARM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA O-ARM MARKET SIZE, BY PURCHASE MODEL, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA O-ARM MARKET SIZE, BY LEASING, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA O-ARM MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA O-ARM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA O-ARM MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA O-ARM MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA O-ARM MARKET SIZE, BY SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA O-ARM MARKET SIZE, BY MINIMALLY INVASIVE SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA O-ARM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA O-ARM MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA O-ARM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA O-ARM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA O-ARM MARKET SIZE, BY PURCHASE MODEL, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA O-ARM MARKET SIZE, BY LEASING, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA O-ARM MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA O-ARM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA O-ARM MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA O-ARM MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA O-ARM MARKET SIZE, BY SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA O-ARM MARKET SIZE, BY MINIMALLY INVASIVE SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA O-ARM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA O-ARM MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA O-ARM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA O-ARM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA O-ARM MARKET SIZE, BY PURCHASE MODEL, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA O-ARM MARKET SIZE, BY LEASING, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA O-ARM MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA O-ARM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA O-ARM MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA O-ARM MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA O-ARM MARKET SIZE, BY SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA O-ARM MARKET SIZE, BY MINIMALLY INVASIVE SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA O-ARM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA O-ARM MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA O-ARM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE O-ARM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE O-ARM MARKET SIZE, BY PURCHASE MODEL, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE O-ARM MARKET SIZE, BY LEASING, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE O-ARM MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE O-ARM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE O-ARM MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE O-ARM MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE O-ARM MARKET SIZE, BY SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE O-ARM MARKET SIZE, BY MINIMALLY INVASIVE SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE O-ARM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE O-ARM MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE O-ARM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST O-ARM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST O-ARM MARKET SIZE, BY PURCHASE MODEL, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST O-ARM MARKET SIZE, BY LEASING, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST O-ARM MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST O-ARM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. MIDDLE EAST O-ARM MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST O-ARM MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST O-ARM MARKET SIZE, BY SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 160. MIDDLE EAST O-ARM MARKET SIZE, BY MINIMALLY INVASIVE SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST O-ARM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST O-ARM MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST O-ARM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA O-ARM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA O-ARM MARKET SIZE, BY PURCHASE MODEL, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA O-ARM MARKET SIZE, BY LEASING, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA O-ARM MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. AFRICA O-ARM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 169. AFRICA O-ARM MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 170. AFRICA O-ARM MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 171. AFRICA O-ARM MARKET SIZE, BY SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 172. AFRICA O-ARM MARKET SIZE, BY MINIMALLY INVASIVE SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 173. AFRICA O-ARM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 174. AFRICA O-ARM MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 175. AFRICA O-ARM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 176. ASIA-PACIFIC O-ARM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC O-ARM MARKET SIZE, BY PURCHASE MODEL, 2018-2032 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC O-ARM MARKET SIZE, BY LEASING, 2018-2032 (USD MILLION)
  • TABLE 179. ASIA-PACIFIC O-ARM MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC O-ARM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC O-ARM MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC O-ARM MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC O-ARM MARKET SIZE, BY SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC O-ARM MARKET SIZE, BY MINIMALLY INVASIVE SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC O-ARM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC O-ARM MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC O-ARM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 188. GLOBAL O-ARM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN O-ARM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN O-ARM MARKET SIZE, BY PURCHASE MODEL, 2018-2032 (USD MILLION)
  • TABLE 191. ASEAN O-ARM MARKET SIZE, BY LEASING, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN O-ARM MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN O-ARM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 194. ASEAN O-ARM MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN O-ARM MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 196. ASEAN O-ARM MARKET SIZE, BY SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 197. ASEAN O-ARM MARKET SIZE, BY MINIMALLY INVASIVE SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN O-ARM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN O-ARM MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 200. ASEAN O-ARM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 201. GCC O-ARM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. GCC O-ARM MARKET SIZE, BY PURCHASE MODEL, 2018-2032 (USD MILLION)
  • TABLE 203. GCC O-ARM MARKET SIZE, BY LEASING, 2018-2032 (USD MILLION)
  • TABLE 204. GCC O-ARM MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 205. GCC O-ARM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 206. GCC O-ARM MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 207. GCC O-ARM MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 208. GCC O-ARM MARKET SIZE, BY SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 209. GCC O-ARM MARKET SIZE, BY MINIMALLY INVASIVE SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 210. GCC O-ARM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 211. GCC O-ARM MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 212. GCC O-ARM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPEAN UNION O-ARM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPEAN UNION O-ARM MARKET SIZE, BY PURCHASE MODEL, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPEAN UNION O-ARM MARKET SIZE, BY LEASING, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPEAN UNION O-ARM MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPEAN UNION O-ARM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPEAN UNION O-ARM MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPEAN UNION O-ARM MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPEAN UNION O-ARM MARKET SIZE, BY SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPEAN UNION O-ARM MARKET SIZE, BY MINIMALLY INVASIVE SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPEAN UNION O-ARM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION O-ARM MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION O-ARM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 225. BRICS O-ARM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 226. BRICS O-ARM MARKET SIZE, BY PURCHASE MODEL, 2018-2032 (USD MILLION)
  • TABLE 227. BRICS O-ARM MARKET SIZE, BY LEASING, 2018-2032 (USD MILLION)
  • TABLE 228. BRICS O-ARM MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. BRICS O-ARM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 230. BRICS O-ARM MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 231. BRICS O-ARM MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 232. BRICS O-ARM MARKET SIZE, BY SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 233. BRICS O-ARM MARKET SIZE, BY MINIMALLY INVASIVE SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 234. BRICS O-ARM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 235. BRICS O-ARM MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 236. BRICS O-ARM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 237. G7 O-ARM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 238. G7 O-ARM MARKET SIZE, BY PURCHASE MODEL, 2018-2032 (USD MILLION)
  • TABLE 239. G7 O-ARM MARKET SIZE, BY LEASING, 2018-2032 (USD MILLION)
  • TABLE 240. G7 O-ARM MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 241. G7 O-ARM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 242. G7 O-ARM MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 243. G7 O-ARM MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 244. G7 O-ARM MARKET SIZE, BY SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 245. G7 O-ARM MARKET SIZE, BY MINIMALLY INVASIVE SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 246. G7 O-ARM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 247. G7 O-ARM MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 248. G7 O-ARM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 249. NATO O-ARM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 250. NATO O-ARM MARKET SIZE, BY PURCHASE MODEL, 2018-2032 (USD MILLION)
  • TABLE 251. NATO O-ARM MARKET SIZE, BY LEASING, 2018-2032 (USD MILLION)
  • TABLE 252. NATO O-ARM MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 253. NATO O-ARM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 254. NATO O-ARM MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 255. NATO O-ARM MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 256. NATO O-ARM MARKET SIZE, BY SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 257. NATO O-ARM MARKET SIZE, BY MINIMALLY INVASIVE SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 258. NATO O-ARM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 259. NATO O-ARM MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 260. NATO O-ARM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 261. GLOBAL O-ARM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 262. UNITED STATES O-ARM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 263. UNITED STATES O-ARM MARKET SIZE, BY PURCHASE MODEL, 2018-2032 (USD MILLION)
  • TABLE 264. UNITED STATES O-ARM MARKET SIZE, BY LEASING, 2018-2032 (USD MILLION)
  • TABLE 265. UNITED STATES O-ARM MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 266. UNITED STATES O-ARM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 267. UNITED STATES O-ARM MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 268. UNITED STATES O-ARM MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 269. UNITED STATES O-ARM MARKET SIZE, BY SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 270. UNITED STATES O-ARM MARKET SIZE, BY MINIMALLY INVASIVE SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 271. UNITED STATES O-ARM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 272. UNITED STATES O-ARM MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 273. UNITED STATES O-ARM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 274. CHINA O-ARM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 275. CHINA O-ARM MARKET SIZE, BY PURCHASE MODEL, 2018-2032 (USD MILLION)
  • TABLE 276. CHINA O-ARM MARKET SIZE, BY LEASING, 2018-2032 (USD MILLION)
  • TABLE 277. CHINA O-ARM MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 278. CHINA O-ARM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 279. CHINA O-ARM MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 280. CHINA O-ARM MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 281. CHINA O-ARM MARKET SIZE, BY SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 282. CHINA O-ARM MARKET SIZE, BY MINIMALLY INVASIVE SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 283. CHINA O-ARM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 284. CHINA O-ARM MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 285. CHINA O-ARM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)